| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Invus Global Management, LLC | 8.9% | $13,545,053 | 4,232,829 | Invus Public Equities, L.P. | 31 Dec 2023 | |||
| BAILLIE GIFFORD & CO | 4.1% | $6,142,944 | 1,919,670 | BAILLIE GIFFORD & CO | 31 Dec 2024 |
As of 31 Dec 2025, 14 institutional investors reported holding 5,700,886 shares of Nanobiotix S.A. - Common Stock (NBTX). This represents 12% of the company’s total 46,821,220 outstanding shares.
The largest institutional shareholders of Nanobiotix S.A. - Common Stock (NBTX) together control 12% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 12% | 5,623,816 | 0% | 23% | $130,022,626 |
| MORGAN STANLEY | 0.05% | 22,923 | +864% | 0% | $529,980 |
| MILLENNIUM MANAGEMENT LLC | 0.04% | 16,869 | 0% | $390,011 | |
| Optiver Holding B.V. | 0.03% | 16,225 | +203% | 0.01% | $375,122 |
| MARSHALL WACE, LLP | 0.02% | 9,500 | 0% | $219,641 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.01% | 3,600 | 0% | 0% | $83,232 |
| ROYAL BANK OF CANADA | 0.01% | 2,625 | +2000% | 0% | $61,000 |
| RHUMBLINE ADVISERS | 0.01% | 2,342 | +6997% | 0% | $54,141 |
| UBS Group AG | 0% | 1,530 | -29% | 0% | $35,374 |
| EverSource Wealth Advisors, LLC | 0% | 514 | 0% | 0% | $11,884 |
| OSAIC HOLDINGS, INC. | 0% | 500 | 0% | $11,560 | |
| GAMMA Investing LLC | 0% | 229 | 0% | $5,294 | |
| WELLS FARGO & COMPANY/MN | 0% | 200 | 0% | $4,624 | |
| NATIONAL BANK OF CANADA /FI/ | 0% | 13 | 0% | 0% | $300 |
| BARCLAYS PLC | 0% | 0 | -100% | $0 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 5,700,886 | $131,804,789 | +$1,261,855 | $23.12 | 14 |
| 2025 Q3 | 5,644,984 | $106,633,384 | +$3,364 | $18.89 | 11 |
| 2025 Q2 | 5,645,042 | $25,554,914 | -$414,807 | $4.73 | 8 |
| 2025 Q1 | 5,761,181 | $20,624,582 | -$1,004,115 | $3.58 | 10 |
| 2024 Q4 | 6,067,225 | $17,419,035 | -$1,000,406 | $2.87 | 16 |
| 2024 Q3 | 6,417,922 | $36,903,052 | -$14,323,739 | $5.75 | 9 |
| 2024 Q2 | 9,293,451 | $46,466,940 | -$68,645 | $5.00 | 11 |
| 2024 Q1 | 9,306,982 | $59,748,622 | +$230,299 | $6.50 | 11 |
| 2023 Q4 | 9,271,406 | $67,496,071 | +$33,478,773 | $7.28 | 12 |
| 2023 Q3 | 4,468,338 | $39,097,959 | +$8,789,679 | $8.75 | 9 |
| 2023 Q2 | 3,463,804 | $17,715,486 | +$5,090 | $5.07 | 5 |
| 2023 Q1 | 3,462,800 | $12,353,370 | -$3,852 | $3.52 | 4 |
| 2022 Q4 | 3,463,881 | $12,194,444 | +$2,929 | $3.67 | 5 |
| 2022 Q3 | 3,463,083 | $12,218,000 | -$49,000 | $3.54 | 5 |
| 2022 Q2 | 3,476,092 | $13,278,000 | -$18,904 | $3.78 | 6 |
| 2022 Q1 | 3,481,131 | $25,974,000 | -$293,544 | $7.25 | 6 |
| 2021 Q4 | 3,520,885 | $28,772,000 | -$6,268,938 | $8.10 | 7 |
| 2021 Q3 | 4,094,109 | $46,466,000 | -$10,429,241 | $11.36 | 9 |
| 2021 Q2 | 4,852,401 | $66,866,000 | -$203,431 | $13.78 | 10 |
| 2021 Q1 | 4,867,161 | $73,173,000 | -$987,342 | $15.04 | 10 |
| 2020 Q4 | 4,926,653 | $81,291,000 | +$81,291,000 | $16.50 | 11 |